Introduction and first vote

Date 29 September 2014
Event ESMO 2014
Session Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT)
Topics Anti-Cancer Agents & Biologic Therapy
Prostate Cancer
Presenter Eleni Efstathiou
Authors E. Efstathiou
  • Oncology, University of Texas MD Anderson Cancer Center, TX77030 - HOUSTON/US